Interleukin-18 expression increases in response to neurovascular damage following soman-induced status epilepticus in rats

Journal of Inflammation (United Kingdom)

Volumn 12, Issue 1, 2015, Pages

  Johnson, Erik A ^a   Guignet, Michelle A ^a   Dao, Thuy L ^a   Hamilton, Tracey A ^a   Kan, Robert K ^a  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

Hippocampus; Interleukin 18; Macrophage; Neutrophil; Piriform cortex; Soman (GD); Status epilepticus; T cell; Thalamus

Indexed keywords

EOSIN; GAMMA INTERFERON; HEMATOXYLIN; INTERLEUKIN 18; SOMAN; VASCULOTROPIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN HEMORRHAGE; BRAIN REGION; CELL SPECIFICITY; CONTROLLED STUDY; ENDOTHELIUM CELL; EPILEPTIC STATE; HIPPOCAMPUS; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PYRIFORM CORTEX; RAT; T LYMPHOCYTE; THALAMUS; TRANSMISSION ELECTRON MICROSCOPY;

RATTUS;

EID: 84937423930     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/s12950-015-0089-9     Document Type: Article

References (54)

1. Bataillard A et al. Cardiovascular consequences of organophosphorus poisoning and of antidotes in conscious unrestrained rats. Pharmacol Toxicol. 1990;67(1):27-35.
2. Letienne R et al. Soman-induced hypertension in conscious rats is mediated by prolonged central muscarinic stimulation. Fundam Clin Pharmacol. 1999;13(4):468-74.
3. Shih TM, Scremin OU. Cerebral blood flow and metabolism in soman-induced convulsions. Brain Res Bull. 1992;28(5):735-42.
4. McDonough Jr. JH et al. Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment. Neurotoxicology. 1995;16(1):123-32.
5. Zimmer LA, Ennis M, Shipley MT. Soman-induced seizures rapidly activate astrocytes and microglia in discrete brain regions. J Comp Neurol. 1997;378(4):482-92.
6. Baille V et al. Soman-induced convulsions: the neuropathology revisited. Toxicology. 2005;215(1-2):1-24.
7. McLeod Jr. CG, Singer AW, Harrington DG. Acute neuropathology in soman poisoned rats. Neurotoxicology. 1984;5(2):53-7.
8. Johnson EA, Kan RK. The acute phase response and soman-induced status epilepticus: temporal, regional and cellular changes in rat brain cytokine concentrations. J Neuroinflammation. 2010;7:40.
9. Johnson EA et al. Increased expression of the chemokines CXCL1 and MIP-1alpha by resident brain cells precedes neutrophil infiltration in the brain following prolonged soman-induced status epilepticus in rats. J Neuroinflammation. 2011;8:41.
10. Arend WP, Palmer G, Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev. 2008;223:20-38.
11. Prinz M, Hanisch UK. Murine microglial cells produce and respond to interleukin-18. J Neurochem. 1999;72(5):2215-8.
12. Culhane AC et al. Cloning of rat brain interleukin-18 cDNA. Mol Psychiatry. 1998;3(4):362-6.
13. Wheeler RD et al. Detection of the interleukin 18 family in rat brain by RT-PCR. Brain Res Mol Brain Res. 2000;77(2):290-3.
14. Ryu HJ et al. The protective effects of interleukin-18 and interferon-gamma on neuronal damages in the rat hippocampus following status epilepticus. Neuroscience. 2010;170(3):711-21.
15. Gerdes N et al. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med. 2002;195(2):245-57.
16. Conti B et al. Cultures of astrocytes and microglia express interleukin 18. Brain Res Mol Brain Res. 1999;67(1):46-52.
17. Alboni S et al. Interleukin 18 in the CNS. J Neuroinflammation. 2010;7:9.
18. Szabo SJ et al. Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol. 2003;21:713-58.
19. Dai SM et al. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis. Arthritis Rheum. 2004;50(2):432-43.
20. Jeon GS et al. Glial expression of interleukin-18 and its receptor after excitotoxic damage in the mouse hippocampus. Neurochem Res. 2008;33(1):179-84.
21. Zhang XM et al. IL-18 deficiency aggravates kainic acid-induced hippocampal neurodegeneration in C57BL/6 mice due to an overcompensation by IL-12. Exp Neurol. 2007;205(1):64-73.
22. Morel JC et al. A novel role for interleukin-18 in adhesion molecule induction through NF kappa B and phosphatidylinositol (PI) 3-kinase-dependent signal transduction pathways. J Biol Chem. 2001;276(40):37069-75.
23. Leung BP et al. A role for IL-18 in neutrophil activation. J Immunol. 2001;167(5):2879-86.
24. Dai SM et al. Cellular targets of interleukin-18 in rheumatoid arthritis. Ann Rheum Dis. 2007;66(11):1411-8.
25. Ariel A et al. IL-12 and IL-18 induce MAP kinase-dependent adhesion of T cells to extracellular matrix components. J Leukoc Biol. 2002;72(1):192-8.
26. Morel JC et al. Signal transduction pathways involved in rheumatoid arthritis synovial fibroblast interleukin-18-induced vascular cell adhesion molecule-1 expression. J Biol Chem. 2002;277(38):34679-91.
27. Gracie JA, Robertson SE, McInnes IB. Interleukin-18. J Leukoc Biol. 2003;73(2):213-24.
28. Ogura T et al. Interleukin-18 stimulates hematopoietic cytokine and growth factor formation and augments circulating granulocytes in mice. Blood. 2001;98(7):2101-7.
29. Yoo JK et al. IL-18 induces monocyte chemotactic protein-1 production in macrophages through the phosphatidylinositol 3-kinase/Akt and MEK/ERK1/2 pathways. J Immunol. 2005;175(12):8280-6.
30. Yoshimoto T et al. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells. Proc Natl Acad Sci USA. 1997;94(8):3948-53.
31. Micallef MJ et al. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur J Immunol. 1996;26(7):1647-51.
32. Walker W et al. IL-18 and CD28 use distinct molecular mechanisms to enhance NK cell production of IL-12-induced IFN-gamma. J Immunol. 1999;162(10):5894-901.
33. Dinarello CA et al. Overview of interleukin-18: more than an interferon-gamma inducing factor. J Leukoc Biol. 1998;63(6):658-64.
34. Nakanishi K et al. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol. 2001;19:423-74.
35. Watanabe-Fukunaga R et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 1992;356(6367):314-7.
36. Cho ML et al. Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways. Immunol Lett. 2006;103(2):159-66.
37. Park CC et al. Evidence of IL-18 as a novel angiogenic mediator. J Immunol. 2001;167(3):1644-53.
38. Bernardini G et al. Analysis of the role of chemokines in angiogenesis. J Immunol Methods. 2003;273(1-2):83-101.
39. Shichita T et al. Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med. 2009;15(8):946-50.
40. Ren X et al. Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J Neurosci. 2011;31(23):8556-63.
41. Shih TM, McDonough Jr. JH. Neurochemical mechanisms in soman-induced seizures. J Appl Toxicol. 1997;17(4):255-64.
42. Koplovitz I, Skvorak JP. Electrocorticographic changes during generalized convulsive status epilepticus in soman intoxicated rats. Epilepsy Res. 1998;30(2):159-64.
43. Johnson EA et al. Cell-specific DNA fragmentation may be attenuated by a survivin-dependent mechanism after traumatic brain injury in rats. Exp Brain Res. 2005;167(1):17-26.
44. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. San Diego: Elsevier Academic Press; 2005. p. 205.
45. Hedtjarn M et al. Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci. 2002;22(14):5910-9.
46. Yatsiv I et al. Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury. J Cereb Blood Flow Metab. 2002;22(8):971-8.
47. Andoh T et al. Protective effect of IL-18 on kainate-and IL-1 beta-induced cerebellar ataxia in mice. J Immunol. 2008;180(4):2322-8.
48. Zhang XM et al. Kainic acid-induced microglial activation is attenuated in aged interleukin-18 deficient mice. J Neuroinflammation. 2010;7:26.
49. Mori I et al. Impaired microglial activation in the brain of IL-18-gene-disrupted mice after neurovirulent influenza A virus infection. Virology. 2001;287(1):163-70.
50. Bouchaud C et al. The role of nitric oxide in the neuropathology in soman intoxication. Brain Res. 1994;660(2):249-54.
51. Lallement G et al. Acute soman poisoning in primates neither pretreated nor receiving immediate therapy: value of gacyclidine (GK-11) in delayed medical support. Arch Toxicol. 1999;73(2):115-22.
52. Lemercier G et al. Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organophosphorus compound. Acta Neuropathol. 1983;61(2):123-9.
53. Collombet JM et al. Soman poisoning induces delayed astrogliotic scar and angiogenesis in damaged mouse brain areas. Neurotoxicology. 2007;28(1):38-48.
54. Jander S, Schroeter M, Stoll G. Interleukin-18 expression after focal ischemia of the rat brain: association with the late-stage inflammatory response. J Cereb Blood Flow Metab. 2002;22(1):62-70.